DS Pharma Biomedical Co Ltd - Company Review
DS Pharma Biomedical Co Ltd - Company ReviewSummary
DS Pharma Biomedical Co Ltd (DS Pharma), a subsidiary of Sumitomo Dainippon Pharma Co Ltd is a medical device company that manufactures and markets in-vitro diagnostic test kits and cell products. The company offers diagnostic products such as bone and ca metabolism; point of care testing, infections, H-FABP and biomarker; and myocardiac infarction diagnostic kits. Its cell based products comprise point of cell assay, cell lines and medium for stem cells. DS Pharma develops supporting technologies for regenerative and cellular medicine, and tools for scientific community. The company offers research and development services and provides development of novel biomarkers for unmet medical needs in diagnostics. Its products are used in CNS, oncology, regenerative medicine and other therapeutic areas. The company distributes cells to researchers. DS Pharma is headquartered in Suita, Japan.
This comprehensive company report of DS Pharma Biomedical Co Ltd provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.